Happy holidays from the entire staff here at Diabetes in Control. This week we add another SGLT-2 inhibitor to our armada of diabetes medications. This new drug, Ertugliflozin, (see news flash) is coming to the market as a stand alone and in combination with both a DPP-4 inhibitor and Metformin. …

Poll finds less than half of health care professionals aware of newest drug up for FDA approval.

How can health care practitioners play a more prominent role in helping patients to take prescribed medications?

The first study to examine overtreatment and deintensification in a Medicare population with diabetes.

Injectable extended-release formulation of exenatide in patients with T2DM at a wide range of heart disease risk appeared not to cause increase in overall risk.

Study reports Vitamin D supplementation may improve HbA1c and lower cholesterol.

Medication also found to further aids in reducing daily insulin dose.

Would you be interested in learning about a program that can determine the best individual treatments for patients with type 2, based on what the patient can afford using their insurance? Follow the link to see how your colleagues responded.

A 47-year-old patient returns for a follow-up visit. He currently takes metformin 2000 mg daily, but is not achieving his glycemic target of A1C <7 %. His current A1C is 8.0%. You would like to add a second medication to his regimen, however, he voices concern that he is no longer covered by any health insurance and is worried about how to pay for his medications. Taking his concern into consideration, what drug would you add to metformin? A. DPP-4 inhibitor B. Thiazolidine C. Sulfonylurea D. Meglitinide E. SGLT2 Inhibitor F. GLP-1 Agonists Follow the link to see the answer.

With 'SiDiary iPhone' you are able to keep your diabetes logbook (blood glucose levels, blood pressure, medication, carbohydrates, etc.) without the slightest effort as you are already used to from the pc-version of SiDiary 6.